Abbott Laboratories (ABT) Stock Price Today
Aura AI Summary
Key Stats
- $187.95BMarket Cap
- 6,175,599Volume
- HealthSector
- $130.5952W High
- $82.5752W Low
- 96 DaysTypical Hold Time
- $214.81BEnterprise Value
- 2.32%Div Yield
- -Trading Activity
Track Abbott Laboratories (ABT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Abbott Laboratories has traded between a low of $82.57 and a high of $130.59, highlighting its annual price range. Buy and sell Abbott Laboratories shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Most Recent News
Walk assist robot market to grow 15% CAGR by 2031, driven by AI, aging population, and stroke rehab demand
The global walk assist robot market is projected to grow at a 15.01% CAGR from 2024 to 2031, fueled by advances in AI, machine learning, and hybrid wearable technology. Rising stroke incidence and an aging population are increasing demand for these r...

Anti-obesity drug market to hit $64.96B by 2035, led by Eli Lilly and Novo Nordisk with strong new drug launches.
The global anti-obesity drugs market is projected to grow from USD 8.96 billion in 2026 to USD 64.96 billion by 2035, driven by a CAGR of 24.71%. Eli Lilly and Novo Nordisk dominate the market with blockbuster drugs like Mounjaro, Zepbound, and Wegov...

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017
Nike is under pressure to clarify its cost-cutting plans as it prepares for its first investor day since 2017, scheduled for November 16–17. Despite efforts led by CEO Elliott Hill to turn the company around, management expects revenue to decline by ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.